Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Factors Influencing Peripheral Blood Progenitor Cell Yield After 2 nd Mobilization With G-CSF In Allogeneic Donors

Kristina Hölig, MD, Michael Kramer, PhD, Kristin Zimmer, MD, Matthias Blechschmidt, MD, Kirsten Poppe-Thiede, MD, Martin Bornhäuser, MD, Gerhard Ehninger, MD

Blood (2013) 122 (21): 3274.

https://doi.org/10.1182/blood.V122.21.3274.3274

Published: 2013

Journal Articles

Severe Pulmonary Adverse Events in Healthy Unrelated Donors of Peripheral Blood Stem Cells Following G-CSF Administration,

Katrin Wetzko, MD, Matthias Blechschmidt, MD, Kristina Hölig, MD, Kirsten Poppe-Thiede, MD, Susanne Ganepola, MD, Roman Fischbach, MD, Rainer Ordemann, MD, Michael Laniado, MD, Bernhard Schulte-Hubbert, MD, Markus Schuler, MD, Livia Cotta, MD, Dietrich Braumann, MD, Gerhard Ehninger, MD, Frank Kroschinsky, MD

Blood (2011) 118 (21): 4057.

https://doi.org/10.1182/blood.V118.21.4057.4057

Published: 2011

Journal Articles

Changes in Bone Metabolism Induced by Short-Term Treatment with G-CSF for the Mobilization of Allogeneic Hematopoietic Progenitor Cells.

Frank P. Kroschinsky, MD, Sybille Bergmann, Kirsten Poppe-Thiede, MD, Gabriele Siegert, Claudia Rutt, Gerhard Ehninger

Blood (2005) 106 (11): 1772.

https://doi.org/10.1182/blood.V106.11.1772.1772

Published: 2005

Journal Articles

Plasma Concentrations and AUC of Pegfilgrastim Have No Impact on Its Efficacy in Peripheral Blood Progenitor Cell Mobilization.

Frank P. Kroschinsky, MD, Eberhard Schleyer, MD, Kristina Hoelig, MD, Uta Oelschlaegel, PhD, Rainer Ordemann, MD, Kirsten Poppe-Thiede, MD, Markus A. Schaich, MD, Claudia Rutt, MD, Gerhard Ehninger, MD

Blood (2005) 106 (11): 5321.

https://doi.org/10.1182/blood.V106.11.5321.5321

Published: 2005

Journal Articles

Differences in the Expression of Adhesion Molecules and Mobilization Efficacy in Healthy Stem Cell Donors and Patients with Hematologic Malignancies.

Uta Oelschlaegel, Kirsten Poppe-Thiede, Kristina Hoelig, Martin Bornhaeuser, Gerhard Ehninger, Frank Kroschinsky

Blood (2004) 104 (11): 2879.

https://doi.org/10.1182/blood.V104.11.2879.2879

Published: 2004

Journal Articles

Feasibility and Efficacy of Peripheral Blood Progenitor Cell Mobilisation with Pegfilgrastim for Allogeneic Stem Cell Transplantation.

Frank Kroschinsky, MD, Kristina Hoelig, MD, Rainer Ordemann, MD, Astrid Haack, Kirsten Poppe-Thiede, MD, Matthias Blechschmidt, MD, Gabi Rall, Martin Bornhaeuser, MD, Eberhard Schleyer, MD, Claudia Rutt, Gerhard Ehninger, MD

Blood (2004) 104 (11): 5003.

https://doi.org/10.1182/blood.V104.11.5003.5003

Published: 2004

Journal Articles

Is There a Risk in Allogeneic PBPC Donation for Autoimmune Diseases Due to Short-Term Treatment with rhG-CSF? Preliminary Results of a Prospective Study in 100 Unrelated Stem Cell Donors.

Frank Kroschinsky, MD, Karsten Conrad, MD, Kirsten Poppe-Thiede, MD, Rainer Ordemann, MD, Andrea Schlaupitz, Gabi Rall, Claudia Rutt, Gerhard Ehninger, MD

Blood (2004) 104 (11): 2190.

https://doi.org/10.1182/blood.V104.11.2190.2190

Published: 2004

NARROW

Factors Influencing Peripheral Blood Progenitor Cell Yield After 2 nd Mobilization With G-CSF In Allogeneic Donors

Severe Pulmonary Adverse Events in Healthy Unrelated Donors of Peripheral Blood Stem Cells Following G-CSF Administration,

Changes in Bone Metabolism Induced by Short-Term Treatment with G-CSF for the Mobilization of Allogeneic Hematopoietic Progenitor Cells.

Plasma Concentrations and AUC of Pegfilgrastim Have No Impact on Its Efficacy in Peripheral Blood Progenitor Cell Mobilization.

Differences in the Expression of Adhesion Molecules and Mobilization Efficacy in Healthy Stem Cell Donors and Patients with Hematologic Malignancies.

Feasibility and Efficacy of Peripheral Blood Progenitor Cell Mobilisation with Pegfilgrastim for Allogeneic Stem Cell Transplantation.

Is There a Risk in Allogeneic PBPC Donation for Autoimmune Diseases Due to Short-Term Treatment with rhG-CSF? Preliminary Results of a Prospective Study in 100 Unrelated Stem Cell Donors.

Email alerts

ASH Publications

American Society of Hematology

Factors Influencing Peripheral Blood Progenitor Cell Yield After 2 nd Mobilization With G-CSF In Allogeneic Donors

Severe Pulmonary Adverse Events in Healthy Unrelated Donors of Peripheral Blood Stem Cells Following G-CSF Administration,

Changes in Bone Metabolism Induced by Short-Term Treatment with G-CSF for the Mobilization of Allogeneic Hematopoietic Progenitor Cells.

Plasma Concentrations and AUC of Pegfilgrastim Have No Impact on Its Efficacy in Peripheral Blood Progenitor Cell Mobilization.

Differences in the Expression of Adhesion Molecules and Mobilization Efficacy in Healthy Stem Cell Donors and Patients with Hematologic Malignancies.

Feasibility and Efficacy of Peripheral Blood Progenitor Cell Mobilisation with Pegfilgrastim for Allogeneic Stem Cell Transplantation.

Is There a Risk in Allogeneic PBPC Donation for Autoimmune Diseases Due to Short-Term Treatment with rhG-CSF? Preliminary Results of a Prospective Study in 100 Unrelated Stem Cell Donors.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only